|
Mechanism5-HT1B receptor agonists [+1] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date11 Apr 2002 |
|
MechanismHMG-CoA reductase inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date17 Dec 1996 |
100 Clinical Results associated with Upjohn Manufacturing Ireland Unlimited Co.
0 Patents (Medical) associated with Upjohn Manufacturing Ireland Unlimited Co.
100 Deals associated with Upjohn Manufacturing Ireland Unlimited Co.
100 Translational Medicine associated with Upjohn Manufacturing Ireland Unlimited Co.